Private Equity
Iron Pillar has set out to raise a $150 million venture capital fund, according to a filing with the SEC.
1 min read · 17 July 2017
Moment Ventures has raised $12.5 million for its sophomore fund, according to an SEC filing. The target was $50 million. Based in Palo Alto, California, Moment is a seed and early-stage venture firm that invests in the infrastructure of everything companies.
1 min read · 17 July 2017
WestWave Capital has set out to raise $35 million for a maiden venture fund. The firm is being run by Warren "Bunny" Weiss, presently a general partner at Foundation Capital.
1 min read · 14 July 2017
Los Angeles-based Peate Ventures has raised $1.75 million for its second fund, according to an SEC filing. The target is $50 million. The firm invests in insurance technology, digital health and entertainment companies.
1 min read · 14 July 2017
2 min read · 13 July 2017
Seattle and San Francisco-based venture firm Maveron has raised $9.975 million for its sixth entrepreneurs' fund, according to an SEC filing. The target is $15 million.
1 min read · 13 July 2017
6 min read · 12 July 2017
Google, whose interest in artificial intelligence includes its Google.ai project to incorporate AI technology across all of its products, has launched Gradient Ventures on Tuesday as an independent investment vehicle. The amount of capital available to invest was not disclosed. The firm will invest in early-stage startups focused on AI and also provide portfolio companies with resources and access to experts and boot camps in AI, according to a blog post by co-founder and Managing Partner Ann Patterson.
1 min read · 12 July 2017
Silicon Valley-based Autotech Ventures has raised more than $120 million for its debut fund. The fund will focus on backing ground transportation startups. The fund's investors include BorgWarner and Autoliv.
3 min read · 12 July 2017
Indianapolis-based BioCrossroads has raised $5 million for its targeted $12 million third fund, Indiana Seed Fund III, according to a regulatory filing. As part of the Central Indiana Corporate Partnership, BioCrossroads invests in life sciences companies based in Indiana and is led by David Lawther Johnson. Three investors have committed to the fund, according to the filing.
1 min read · 12 July 2017